Skip to main content
Signal8

Liminatus Pharma, Inc. (LIMNW)

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Liminatus Pharma, Inc. Warrants logo

Liminatus Pharma, Inc. Warrants

NASDAQ:LIMNWSub-class of LIMNHealthcare
+13.96%$0.0400
Mkt Cap$54K
EV-
Float-
O/S1.34M
VOL251 sh
$ Vol$10
RVOL1.31×
Inst Own-
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 13, 20260.04500.04500.04500.04501
Nov 12, 20260.04000.04000.04000.0400251
Nov 10, 20260.03510.04000.03510.0351117
Nov 6, 20260.03500.03510.03500.0351600
Nov 2, 20260.03520.03520.03520.035245
Oct 28, 20260.04000.04000.04000.0400138
Oct 16, 20260.05000.05000.05000.050055
Oct 15, 20260.04000.04000.04000.0400213
Oct 12, 20260.04350.04350.04350.0435100
Oct 8, 20260.04990.04990.04970.0497800
Oct 7, 20260.04400.04400.03700.03703,650
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(24)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources: 13F
Insiders & Institutional Holders
About

Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer.

The company's headquarters are located in La Palma, California.

Key Metrics
Market Cap$53,728
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 1.34M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
CountryUSUS
IPO DateMay 1, 2025
Shares Outstanding1.34M
Authorized Shares
Float-
52-Week Range
$0.0300$0.1949
$0.0400(6th percentile)
Volume
Average Daily Volume192
251 today vs 192 avg(+31%)

30d Avg

192

60d Avg

541

90d Avg

1.34K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Liminatus Pharma, Inc. (NASDAQ: LIMNW) traded at $0.0400 on Nov 12, 2026, up 13.96% from the previous close of $0.0351. 52-week range: $0.0300 to $0.1949. The company is in the Healthcare sector (Biotechnology).